Articles

Increasing evidence that the IRA is probably not harming pharmaceutical innovation.

In a candid discussion with INET’s Lynn Parramore, Dr. Phillip Alvelda highlights the imminent dangers of long COVID, criticizing governments and health agencies for ongoing preventable suffering and deaths. *This is Part 2 of a two-part interview.

An ensemble of mechanisms enables cloud hegemons (Microsoft, Google, Amazon) to plan the whole AI knowledge and innovation network by weaponizing interdependence in networks.

Behind bogus promises of job creation and economic growth lies a dangerous agenda to shred social safety nets.

Programs for expedited review may be preferentially reducing the development costs for conditions with lesser disease burden, potentially making investments in addressing the most significant disease burdens even less appealing and exacerbating the market failure further.

Reinterpreting Bagehot’s mature work as the origin of the key currency tradition

When working within the same employment spell, female workers, particularly those of color and those working in low-wage service and care jobs, earn significantly less when facing greater volatility than their male counterparts or those working in non-service, non-care occupations.

Why did so many Dutch voters vote for the far-right Geert Wilders?

What sort of effective democratic political system does the United States want and need?

The tech giant is in the hot seat, but it’s going to be a “big fight,” warns antitrust expert Mark Glick.